All questions are shown as received by the Trust.
Q1. How many patients have been treated (for any condition) in the last 4 months with:
a. Benralizumab
b. Dupilumab
c. Omalizumab
d. Reslizumab
e. Mepolizumab
f. Tezepelumab
All questions are shown as received by the Trust.
Q1. How many patients have been treated (for any condition) in the last 4 months with:
a. Benralizumab
b. Dupilumab
c. Omalizumab
d. Reslizumab
e. Mepolizumab
f. Tezepelumab